Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11504426
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist
granted -
US 11498970
Human antibodies to the human glucagon receptor and methods of use thereof to lower blood glucose or ketone levels
granted -
US 11498969
Compositions and methods for treating juvenile idiopathic arthritis
granted -
US 11492392
Polynucleotides encoding anti-C5 antibodies
granted -
US 11491237
Cyclodextrin protein drug conjugates
granted -
US 11491222
Method of treating lower back pain
granted -
US 11485958
HSD17B13 variants and uses thereof
granted -
US 11485793
Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind MUC16 and CD3, and uses thereof
granted -
US 11485788
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor
granted -
US 11485770
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11479602
Methods of treating C5-associated diseases comprising administering anti-C5 antibodies
granted -
US 11472870
Pharmaceutical composition for safe and effective treatment of knee and/or hip pain
granted -
US 11472861
Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
granted -
US 11464830
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 11459374
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11459373
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11453721
Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof
granted -
US 11453714
Human antibodies to influenza hemagglutinin
granted -
US 11446389
Maytansinoid derivatives, conjugates thereof, and methods of use
granted -
US 11440950
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11439683
Anti-angiogenic therapy of metastatic colorectal cancer
granted -
US 11434300
Methods and antibody compositions for tumor treatment
granted -
US 11421036
Methods of treating eosinophilic esophagitis by administering an antibody which inhibits interleukin-4 receptor (IL-4R)
granted -
US 11419318
Genetically modified rat comprising a humanized TRKB locus
granted